Quality, Standards & Compliance

|2 min read

Five Hard-Hitting Quotes from the 2026 Lab Manager Leadership Summit

Words of Curtiss McNair, Jr., Stacey Metzler, and others can guide clinical lab managers
|3 min read

AI Is Entering the Lab. Are Lab Managers Ready?

The lab is adopting AI faster than it can be validated. To get it right, managers must apply the same scrutiny they would to any other tool
|3 min read

Sapio Sciences Integrates Claude AI, Aiming to Simplify Lab Data Access

Integration of Anthropic’s Claude AI assistant with Sapio Elain aims to unify data retrieval, analysis, and workflow automation across ELN and LIMS from a single conversational interface
|3 min read

PFAS Exposure Is Accelerating Aging: What New Research Shows About ‘Forever Chemicals’

New research found links between PFAS exposure and advanced mortality- and metabolism-related aging, with effects dependent on sex and age
|2 min read

The US Is Driving a Public Health Emergency of International Concern

Experts call for global collaboration to mitigate the harms of US policy changes
|1 min read

Clinical Water Decisions Start Where Purity Specs End

A seven-criteria evaluation framework for clinical labs making a capital water system purchase
Sponsored by
|1 min read

DEA Places Bromazolam in Schedule I, Signaling New Lab Compliance Requirements

Forensic and toxicology labs handling or testing this designer benzodiazepine must follow updated Schedule I regulations
|2 min read

Amplified Sciences Achieves CAP Accreditation for Cutting-Edge Diagnostic Lab

Gold standard milestone clears the path for national expansion of PanCystPro™ assay
|1 min read

Standardizing Oncology Assays: A Guide to Cell Line-Derived Reference Materials

Identify the limitations of patient tissue controls in genetic testing and examine the verification data supporting cell line-derived standards
Sponsored by
|1 min read

Move Past the Limitations of Synthetic Reference Standards in Cancer Research

A review of cell line-derived reference standards for the investigation and molecular profiling of myeloid malignancies
Sponsored by
|5 min read

Medicare Is Experimenting with Having AI Review Claims—a Cost-Saving Measure That Could Risk Denying Needed Care

A new pilot brings some automated treatment decisions from Medicare Advantage to traditional Medicare
|3 min read

Regulating the Future: How the FDA Is Defining the Role of AI in Clinical Development

The FDA is embracing a data-driven, patient-centered approach to clinical trials
Page 2 of 42